Elobixibat hydrate is a medication used to treat chronic constipation by inhibiting the ileal bile acid transporter (IBAT). It increases the concentration of bile acids in the colon, promoting bowel movements and relieving constipation. Its therapeutic use is listed as laxatives. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Goofice (TN) and Elobixibat monohydrate. Its PubChem CID is 121494007.
Elobixibat hydrate
| CAS No | 1633824-78-8 |
|---|---|
| Molecular Formula | C36H47N3O8S2 |
| Molecular Weight | 713.9 g/mol |
| Synonyms | 2-[[(2R)-2-[[2-[(3,3-dibutyl-7-methylsulfanyl-1,1-dioxo-5-phenyl-2,4-dihydro-1λ6,5-benzothiazepin-8-yl)oxy]acetyl]amino]-2-phenylacetyl]amino]acetic acid;hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Elobixibat hydrate is a medication used to treat chronic constipation by inhibiting the ileal bile acid transporter (IBAT). It increases the concentration of bile acids in the colon, promoting bowel movements and relieving constipation.
The listed CAS number is 1633824-78-8.
The listed molecular formula is C36H47N3O8S2.
The listed molecular weight is 713.9 g/mol.
2-[[(2R)-2-[[2-[(3,3-dibutyl-7-methylsulfanyl-1,1-dioxo-5-phenyl-2,4-dihydro-1λ6,5-benzothiazepin-8-yl)oxy]acetyl]amino]-2-phenylacetyl]amino]acetic acid;hydrate.
The source lists Goofice (TN) and Elobixibat monohydrate.